Dianthus Therapeutics (DNTH) Amortizatization of Intangibles (2019 - 2025)

Dianthus Therapeutics (DNTH) recorded quarterly Amortizatization of Intangibles of $2.3 million in Q3 2025, up 110.47% quarter-over-quarter from $1.1 million in Q2 2025, and down 1.28% on a YoY basis from $2.3 million in Q3 2024.

Dianthus Therapeutics (DNTH) Amortizatization of Intangibles (2019 - 2025) Analysis & Trends

Dianthus Therapeutics' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $2.3 million for Q3 2025.

  • In Q3 2025, Amortizatization of Intangibles fell 1.28% year-over-year to $2.3 million; the TTM figure through Sep 2025 stood at $3.6 million (up 33.45% YoY), while the FY2024 annual figure was $316000.0, up 9.72% from the prior year.
  • Amortizatization of Intangibles was $2.3 million for Q3 2025 at Dianthus Therapeutics, up from $1.1 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.3 million in Q3 2024 to a low of -$608000.0 in Q4 2023.
  • Historically, Amortizatization of Intangibles has averaged $370210.5 across 5 years, with a median of $106000.0 in 2025.
  • The sharpest annual moves came in 2021 and 2022: Amortizatization of Intangibles plunged 1442.86% in 2021, then jumped 775.64% in 2022.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$78000.0 in 2021, then soared by 775.64% to $527000.0 in 2022, then sank by 215.37% to -$608000.0 in 2023, then jumped by 108.55% to $52000.0 in 2024, then soared by 4344.23% to $2.3 million in 2025.
  • The last three Amortizatization of Intangibles figures came in at $2.3 million (Q3 2025), $1.1 million (Q2 2025), and $106000.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Dianthus Therapeutics 3.60 Bn 3.19 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 2.31 Mn
Sep 30, 2025 2.31 Mn
Jun 30, 2025 1.10 Mn
Jun 30, 2025 1.10 Mn
Mar 31, 2025 106,000.00
Mar 31, 2025 106,000.00
Dec 31, 2024 52,000.00
Dec 31, 2024 52,000.00
Sep 30, 2024 2.34 Mn
Sep 30, 2024 2.34 Mn
Jun 30, 2024 422,000.00
Jun 30, 2024 422,000.00
Mar 31, 2024 518,000.00
Mar 31, 2024 518,000.00
Dec 31, 2023 -608,000.00
Dec 31, 2023 -608,000.00
Sep 30, 2023 330,000.00
Sep 30, 2023 330,000.00
Jun 30, 2023 499,000.00
Jun 30, 2023 499,000.00